Nolato nominates new Board member and re-elects current members
Nolato’s Nomination Committee will nominate Tomas Blomquist as a new member of the Board ahead of the company’s 2021 AGM. Tomas Blomquist, born 1970, has in-depth knowledge and wide-ranging experience within the field of health care, with a focus on diagnostics and medical technology, and over the past two decades has held a number of senior management positions in both global and regional companies. Since 2019 Tomas has been President and CEO of Biotage, which provides solutions for customer workflows in pharmaceutical research and manufacturing, as well as analytical testing and water and